Results and events

Stay informed on our financial results and key events.

2026 results

  • Q1

    Our interim report for the first quarter will be released on May 5, 2026.

  • H1

    Our financial results for the first half will be released on August 20, 2026.

  • 9M

    Our interim report for the first nine months will be released on November 5, 2026.

  • Full-year

    The date for our financial results for the full-year 2026 will be announced later.

2026 events

  • Annual general meeting 2026

    The Annual General Meeting 2026 will be held on March 23, 2026. 

  • Spotlight educational session on Dairy

    On January 8, we conducted a conference call where we shared insights about the industry, Novonesis’ integral part of the industry’s value chain and the growth drivers.

    Watch the webcast
    Download the presentation

2025 results

Previous results and events

EventDateWebcastAnnouncementMore information
Acquisition of dsm-firmenich’s share of Feed Enzyme AllianceFebruary 11, 2025WebcastCompany announcementConference call slides
Annual general meeting 2025April 3, 2025WebcastCompany announcementRead more
2030 strategy updateAugust 21, 2025WebcastCompany announcementConference call slides
EventDateWebcastAnnouncementMore information
Extraordinary shareholders' meetingMarch 10, 2024WebcastResolutionsRead more
Outlook and pro formaMarch 21, 2024WebcastCompany announcementConference call slides
Annual shareholders' meetingApril 30, 2024WebcastResolutionsRead more
Capital Markets DayJune 18, 2024WebcastCompany announcementPresentation
Spotlight on EnergyDecember 18, 2024Webcast-Conference call slides

Stay up to date on our quarterly releases, silent periods and key investor events.

Legacy companies

  • Novozymes

    Explore previous annual reports and quarterly reports for legacy Novozymes.

  • Chr. Hansen

    Explore previous annual reports and quarterly reports for legacy Chr. Hansen.

  • Merger site

Contact investor relations

Should you have any questions about results and events, please don't hesitate to get in touch with our investor relations team.